AAAAAA

   
Results: 1-25 | 26-50 | 51-75 | 76-100 | >>
Results: 26-50/123
IMPACT OF PRETRANSPLANT INTERFERON-ALPHA (IFN-ALPHA) ON OUTCOME OF UNRELATED DONOR MARROW TRANSPLANTS FOR CHRONIC MYELOID-LEUKEMIA (CML) INFIRST CHRONIC PHASE
Authors: MORTON AJ GOOLEY T HANSEN JA APPELBAUM FR BJERKE JW CLIFT R MARTIN PJ PETERSDORF EW SANDERS JE STORB R SULLIVAN KM ANASETTI C
Citation: Aj. Morton et al., IMPACT OF PRETRANSPLANT INTERFERON-ALPHA (IFN-ALPHA) ON OUTCOME OF UNRELATED DONOR MARROW TRANSPLANTS FOR CHRONIC MYELOID-LEUKEMIA (CML) INFIRST CHRONIC PHASE, Blood, 90(10), 1997, pp. 536-536
ACTIVATION-INDUCED T-CELL DEATH DEPENDS ON SUSTAINED OCCUPANCY OF THETCR
Authors: CARPENTER PA ANASETTI C
Citation: Pa. Carpenter et C. Anasetti, ACTIVATION-INDUCED T-CELL DEATH DEPENDS ON SUSTAINED OCCUPANCY OF THETCR, Blood, 90(10), 1997, pp. 606-606
ALLOGENEIC STEM-CELL TRANSPLANTATION FROM HLA-HAPLOIDENTICAL RELATIVES AS TREATMENT FOR CHILDREN WITH HEMATOLOGIC MALIGNANCY - A PHASE I IISTUDY USING MOBILIZED PERIPHERAL-BLOOD PROGENITOR CELLS (PBPCS) THAT HAVE UNDERGONE CD34 SELECTION FOLLOWED BY CD2 DEPLETION/
Authors: YEAGER AM AMYLON M WAGNER J CALDERWOOD S ANASETTI C SENDER L JACOBS C BENYUNES M
Citation: Am. Yeager et al., ALLOGENEIC STEM-CELL TRANSPLANTATION FROM HLA-HAPLOIDENTICAL RELATIVES AS TREATMENT FOR CHILDREN WITH HEMATOLOGIC MALIGNANCY - A PHASE I IISTUDY USING MOBILIZED PERIPHERAL-BLOOD PROGENITOR CELLS (PBPCS) THAT HAVE UNDERGONE CD34 SELECTION FOLLOWED BY CD2 DEPLETION/, Blood, 90(10), 1997, pp. 958-958
ENGRAFTMENT OF UNRELATED DONOR BONE-MARROW - A REPORT FROM THE NATIONAL MARROW DONOR PROGRAM (NMDP)
Authors: DAVIES SM CONFER D KOLLMAN C ANASETTI C ANTIN J GAJEWSKI J CASPER JT NADEMANEE A NOREEN H KING R KERNAN NA
Citation: Sm. Davies et al., ENGRAFTMENT OF UNRELATED DONOR BONE-MARROW - A REPORT FROM THE NATIONAL MARROW DONOR PROGRAM (NMDP), Blood, 90(10), 1997, pp. 1762-1762
MARROW TRANSPLANTATION FROM UNRELATED DONORS FOR PATIENTS WITH APLASTIC-ANEMIA (AA) WHO FAILED IMMUNOSUPPRESSIVE THERAPY
Authors: DEEG HJ SCHOCH G RAMSAY N HARRIS R CASTROMALASPINA H COLLINS R GAJEWSKI J TERRITO M CASPER J MUELLER B ANASETTI C KING R
Citation: Hj. Deeg et al., MARROW TRANSPLANTATION FROM UNRELATED DONORS FOR PATIENTS WITH APLASTIC-ANEMIA (AA) WHO FAILED IMMUNOSUPPRESSIVE THERAPY, Blood, 90(10), 1997, pp. 1763-1763
EXPRESSION OF CD86 ON HUMAN MARROW CD34+ CELLS IDENTIFIES IMMUNOCOMPETENT COMMITTED PRECURSORS OF MACROPHAGES AND DENDRITIC CELLS
Authors: RYNCARZ RE ANASETTI C
Citation: Re. Ryncarz et C. Anasetti, EXPRESSION OF CD86 ON HUMAN MARROW CD34+ CELLS IDENTIFIES IMMUNOCOMPETENT COMMITTED PRECURSORS OF MACROPHAGES AND DENDRITIC CELLS, Blood, 90(10), 1997, pp. 1938-1938
INCREASING SURVIVAL FOR SEVERE APLASTIC-ANEMIA PATIENTS WHO UNDERGO A2ND MARROW TRANSPLANT AFTER REJECTION OF THE FIRST GRAFT
Authors: STUCKI A LEISENRING W SANDMAIER BM SANDERS J ANASETTI C STORB R
Citation: A. Stucki et al., INCREASING SURVIVAL FOR SEVERE APLASTIC-ANEMIA PATIENTS WHO UNDERGO A2ND MARROW TRANSPLANT AFTER REJECTION OF THE FIRST GRAFT, Blood, 90(10), 1997, pp. 2450-2450
PHASE-III STUDY COMPARING TACROLIMUS (FK506) WITH CYCLOSPORINE (CSP) FOR PROPHYLAXIS OF ACUTE GRAFT-VERSUS-HOST DISEASE (GVHD) AFTER MARROWTRANSPLANTATION FROM UNRELATED DONORS
Authors: NASH RA ANTIN J KARANES C FAY J AVALOS B YEAGER AM PRZEPIORKA D DAVIES S PETERSEN F BUELL D FITZSIMMONS W BARTELS P HANSEN J ANASETTI C STORB R RATANATHARATHORN V
Citation: Ra. Nash et al., PHASE-III STUDY COMPARING TACROLIMUS (FK506) WITH CYCLOSPORINE (CSP) FOR PROPHYLAXIS OF ACUTE GRAFT-VERSUS-HOST DISEASE (GVHD) AFTER MARROWTRANSPLANTATION FROM UNRELATED DONORS, Blood, 90(10), 1997, pp. 2499-2499
CHRONIC GRAFT-VERSUS-HOST DISEASE (GVHD) FOLLOWING UNRELATED DONOR TRANSPLANTATION
Authors: MORTON AJ ANASETTI C GOOLEY T FLOWERS MED DEEG HJ HANSEN JA MARTIN PJ SULLIVAN KM
Citation: Aj. Morton et al., CHRONIC GRAFT-VERSUS-HOST DISEASE (GVHD) FOLLOWING UNRELATED DONOR TRANSPLANTATION, Blood, 90(10), 1997, pp. 2623-2623
MARROW TRANSPLANTATION FOR CHRONIC MYELOID-LEUKEMIA - THE INFLUENCE OF PLASMA BUSULFAN LEVELS ON THE OUTCOME OF TRANSPLANTATION
Authors: SLATTERY JT CLIFT RA BUCKNER CD RADICH J STORER B BENSINGER WI SOLL E ANASETTI C BOWDEN R BRYANT E CHAUNCEY T DEEG HJ DONEY KC FLOWERS M GOOLEY T HANSEN JA MARTIN PJ MCDONALD GB NASH R PETERSDORF EW SANDERS JE SCHOCH G STEWART P STORB R SULLIVAN KM THOMAS ED WITHERSPOON RP APPELBAUM FR
Citation: Jt. Slattery et al., MARROW TRANSPLANTATION FOR CHRONIC MYELOID-LEUKEMIA - THE INFLUENCE OF PLASMA BUSULFAN LEVELS ON THE OUTCOME OF TRANSPLANTATION, Blood, 89(8), 1997, pp. 3055-3060
STEM-CELL TRANSPLANTATION FOR SECONDARY ACUTE MYELOID-LEUKEMIA - EVALUATION OF TRANSPLANTATION AS INITIAL THERAPY OR FOLLOWING INDUCTION CHEMOTHERAPY
Authors: ANDERSON JE GOOLEY TA SCHOCH G ANASETTI C BENSINGER WI CLIFT RA HANSEN JA SANDERS JE STORB R APPELBAUM FR
Citation: Je. Anderson et al., STEM-CELL TRANSPLANTATION FOR SECONDARY ACUTE MYELOID-LEUKEMIA - EVALUATION OF TRANSPLANTATION AS INITIAL THERAPY OR FOLLOWING INDUCTION CHEMOTHERAPY, Blood, 89(7), 1997, pp. 2578-2585
ASSOCIATION OF HLA-C DISPARITY WITH GRAFT FAILURE AFTER MARROW TRANSPLANTATION FROM UNRELATED DONORS
Authors: PETERSDORF EW LONGTON GM ANASETTI C MICKELSON EM MCKINNEY SK SMITH AG MARTIN PJ HANSEN JA
Citation: Ew. Petersdorf et al., ASSOCIATION OF HLA-C DISPARITY WITH GRAFT FAILURE AFTER MARROW TRANSPLANTATION FROM UNRELATED DONORS, Blood, 89(5), 1997, pp. 1818-1823
TRANSPLANTATION OF MARROW-CELLS FROM UNRELATED DONORS FOR TREATMENT OF HIGH-RISK ACUTE-LEUKEMIA - THE EFFECT OF LEUKEMIC BURDEN, DONOR HLA-MATCHING, AND MARROW CELL DOSE
Authors: SIERRA J STORER B HANSEN JA BJERKE JW MARTIN PJ PETERSDORF EW APPELBAUM FR BRYANT E CHAUNCEY TR SALE G SANDERS JE STORB R SULLIVAN KM ANASETTI C
Citation: J. Sierra et al., TRANSPLANTATION OF MARROW-CELLS FROM UNRELATED DONORS FOR TREATMENT OF HIGH-RISK ACUTE-LEUKEMIA - THE EFFECT OF LEUKEMIC BURDEN, DONOR HLA-MATCHING, AND MARROW CELL DOSE, Blood, 89(11), 1997, pp. 4226-4235
CYCLOSPORINE OR CYCLOSPORINE PLUS METHYLPREDNISOLONE FOR PROPHYLAXIS OF GRAFT-VERSUS-HOST DISEASE - A PROSPECTIVE, RANDOMIZED TRIAL
Authors: DEEG HJ LIN DY LEISENRING W BOECKH M ANASETTI C APPELBAUM FR CHAUNCEY TR DONEY K FLOWERS M MARTIN P NASH R SCHOCH G SULLIVAN KM WITHERSPOON RP STORB R
Citation: Hj. Deeg et al., CYCLOSPORINE OR CYCLOSPORINE PLUS METHYLPREDNISOLONE FOR PROPHYLAXIS OF GRAFT-VERSUS-HOST DISEASE - A PROSPECTIVE, RANDOMIZED TRIAL, Blood, 89(10), 1997, pp. 3880-3887
LONG-TERM FOLLOW-UP OF ALLOGENEIC MARROW TRANSPLANTS IN PATIENTS WITHAPLASTIC-ANEMIA CONDITIONED BY CYCLOPHOSPHAMIDE COMBINED WITH ANTITHYMOCYTE GLOBULIN
Authors: STORB R LEISENRING W ANASETTI C APPELBAUM FR BUCKNER CD BENSINGER WI CHAUNCEY T CLIFT RA DEEG HJ DONEY KC FLOWERS MED HANSEN JA MARTIN PJ SANDERS KM WITHERSPOON RP
Citation: R. Storb et al., LONG-TERM FOLLOW-UP OF ALLOGENEIC MARROW TRANSPLANTS IN PATIENTS WITHAPLASTIC-ANEMIA CONDITIONED BY CYCLOPHOSPHAMIDE COMBINED WITH ANTITHYMOCYTE GLOBULIN, Blood, 89(10), 1997, pp. 3890-3891
HLA HOMOZYGOSITY AND THE RISK OF GRAFT-VERSUS-HOST DISEASE
Authors: MARTIN PJ PETERSDORF EW ANASETTI C HANSEN JA
Citation: Pj. Martin et al., HLA HOMOZYGOSITY AND THE RISK OF GRAFT-VERSUS-HOST DISEASE, Tissue antigens, 50(2), 1997, pp. 119-123
TRANSPLANTATION OF ALLOGENEIC PERIPHERAL-BLOOD STEM-CELLS MOBILIZED BY RECOMBINANT HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR
Authors: BENSINGER WI CLIFT RA ANASETTI C APPELBAUM FA DEMIRER T ROWLEY S SANDMAIER BM TOROKSTORB B STORB R BUCKNER CD
Citation: Wi. Bensinger et al., TRANSPLANTATION OF ALLOGENEIC PERIPHERAL-BLOOD STEM-CELLS MOBILIZED BY RECOMBINANT HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR, Stem cells, 14(1), 1996, pp. 90-105
REGULATION OF APOPTOSIS INDUCED BY SOLUBLE ANTI-CD3-F(AB(.))2 IN ANTIGEN-ACTIVATED T-CELLS
Authors: YU XZ ANASETTI C
Citation: Xz. Yu et C. Anasetti, REGULATION OF APOPTOSIS INDUCED BY SOLUBLE ANTI-CD3-F(AB(.))2 IN ANTIGEN-ACTIVATED T-CELLS, The FASEB journal, 10(6), 1996, pp. 1140-1140
CONDITIONING REGIMEN-DEPENDENT DISPOSITION OF CYCLOPHOSPHAMIDE AND HYDROXYCYCLOPHOSPHAMIDE IN HUMAN MARROW TRANSPLANTATION PATIENTS
Authors: SLATTERY JT KALHORN TF MCDONALD GB LAMBERT K BUCKNER CD BENSINGER WI ANASETTI C APPELBAUM FR
Citation: Jt. Slattery et al., CONDITIONING REGIMEN-DEPENDENT DISPOSITION OF CYCLOPHOSPHAMIDE AND HYDROXYCYCLOPHOSPHAMIDE IN HUMAN MARROW TRANSPLANTATION PATIENTS, Journal of clinical oncology, 14(5), 1996, pp. 1484-1494
ALLOGENEIC MARROW TRANSPLANTATION FOR MYELODYSPLASTIC SYNDROME WITH ADVANCED DISEASE MORPHOLOGY - A PHASE-II STUDY OF BUSULFAN, CYCLOPHOSPHAMIDE, AND TOTAL-BODY IRRADIATION AND ANALYSIS OF PROGNOSTIC FACTORS
Authors: ANDERSON JE APPELBAUM FR SCHOCH G GOOLEY T ANASETTI C BENSINGER WI BRYANT E BUCKNER CD CHAUNCEY T CLIFT RA DEEG HJ DONEY K FLOWERS M HANSEN JA MARTIN PJ MATTHEWS DC NASH RA SANDERS JE SHULMAN H SULLIVAN KM WITHERSPOON RP STORB R
Citation: Je. Anderson et al., ALLOGENEIC MARROW TRANSPLANTATION FOR MYELODYSPLASTIC SYNDROME WITH ADVANCED DISEASE MORPHOLOGY - A PHASE-II STUDY OF BUSULFAN, CYCLOPHOSPHAMIDE, AND TOTAL-BODY IRRADIATION AND ANALYSIS OF PROGNOSTIC FACTORS, Journal of clinical oncology, 14(1), 1996, pp. 220-226
IMMUNOGENETICS OF ALLOGENEIC HEMATOPOIETIC TRANSPLANTATION
Authors: PETERSDORF EW ANASETTI C MARTIN PJ SIERRA J MICKELSON EM LONGTON G GOOLEY T HANSEN JA
Citation: Ew. Petersdorf et al., IMMUNOGENETICS OF ALLOGENEIC HEMATOPOIETIC TRANSPLANTATION, Experimental hematology, 24(9), 1996, pp. 607-607
ALLOGENIC T-CELL RESPONSE TO HUMAN RHG-CSF MOBILIZED CD34(-BLOOD CELLS() PERIPHERAL)
Authors: RONDELLI D HANSEN JA FORTUNA A LEMOLI RM BANDINI G TURA S ANASETTI C
Citation: D. Rondelli et al., ALLOGENIC T-CELL RESPONSE TO HUMAN RHG-CSF MOBILIZED CD34(-BLOOD CELLS() PERIPHERAL), Experimental hematology, 24(9), 1996, pp. 611-611
MARROW TRANSPLANTATION FROM UNRELATED DONORS (UDT) IN PATIENTS WITH APLASTIC-ANEMIA (AA) WHO HAVE FAILED IMMUNOSUPPRESSIVE THERAPY
Authors: DEEG HJ AMYLON M COLLINS R CHAUNCY T BURDACH S KAIZER H GELLER RB COPELAN E STORB R ANASETTI C HOWE C MUELLER BA
Citation: Hj. Deeg et al., MARROW TRANSPLANTATION FROM UNRELATED DONORS (UDT) IN PATIENTS WITH APLASTIC-ANEMIA (AA) WHO HAVE FAILED IMMUNOSUPPRESSIVE THERAPY, Experimental hematology, 24(9), 1996, pp. 652-652
UNRELATED DONOR MARROW TRANSPLANTATION FOR CHRONIC MYELOID-LEUKEMIA (CML)
Authors: ANASETTI C GOOLEY T CLIFT R PETERSDORF E MARTIN P HANSEN J
Citation: C. Anasetti et al., UNRELATED DONOR MARROW TRANSPLANTATION FOR CHRONIC MYELOID-LEUKEMIA (CML), Experimental hematology, 24(9), 1996, pp. 724-724
GRAFT-REJECTION AND TOXICITY FOLLOWING BONE-MARROW TRANSPLANTATION INRELATION TO BUSULFAN PHARMACOKINETICS (VOL 16, PG 31, 1995)
Authors: SLATTERY JT SANDERS JE BUCKNER CD SCHAFFER RL LAMBERT KW LANGER FP ANASETTI C BENSINGER WI FISHER LD APPELBAUM FR HANSEN JA
Citation: Jt. Slattery et al., GRAFT-REJECTION AND TOXICITY FOLLOWING BONE-MARROW TRANSPLANTATION INRELATION TO BUSULFAN PHARMACOKINETICS (VOL 16, PG 31, 1995), Bone marrow transplantation, 18(4), 1996, pp. 829-830
Risultati: 1-25 | 26-50 | 51-75 | 76-100 | >>